Molnupiravir for SARS-CoV-2 infection: Public health and policy implications. | J Infect;86(2): 121-122, 2023 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Molnupiravir for SARS-CoV-2 infection: Public health and policy implications.

Gray, Edward J; Nguyen-Van-Tam, Jonathan S.

Gray EJ; Formerly, UK Antivirals Task Force, United Kingdom.
Nguyen-Van-Tam JS; Lifespan and Population Health Unit, Nottingham UKMedicine, University of Nottingham School of Medicine, Nottingham, United Kingdom. Electronic address: jvt@nottingham.ac.uk.

J Infect ; 86(2): 121-122, 2023 02.

Article in English | MEDLINE | ID: covidwho-2165572

Subject(s)

COVID-19; Public Health; Humans; SARS-CoV-2; Hydroxylamines; Antiviral Agents

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / COVID-19 Limits: Humans Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2022.10.040

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / COVID-19 Limits: Humans Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2022.10.040